Sleep Disorders Trial, Recruiting NCT07028190 Sponsor: Beijing Tiantan Hospital Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07028190
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with insomnia:

  • Adults between 18 and 64 years old
  • People considered to be in generally good to mild-risk health, as assessed by a standard medical classification system (ASA physical status I–II)
  • People with a body mass index (BMI) between 15 and 30
  • People already scheduled to have a digestive endoscopy procedure under intravenous (IV) sedation
  • People whose sleep difficulties meet the recognised diagnostic standard for insomnia disorder (DSM-5 criteria), confirmed by screening
  • People who score 16 or below on a standard sleep quality questionnaire (where a lower score indicates poorer sleep)

For people with normal sleep:

  • Adults between 18 and 64 years old
  • People considered to be in generally good to mild-risk health, as assessed by a standard medical classification system (ASA physical status I–II)
  • People with a BMI between 15 and 30
  • People already scheduled to have a digestive endoscopy procedure under IV sedation
  • People with no history or signs of insomnia

Who may not be able to join:

  • People who have any neurological condition
  • People who drink alcohol every day
  • People for whom IV sedation medications would not be safe — for example, those with very low blood pressure or shock
  • People who have a known allergy to any medication being used in the study
  • People who are pregnant or breastfeeding
  • People who have sleep apnea
  • People who currently have an acute upper respiratory infection (such as a cold or chest infection)
  • People with a psychological condition who are experiencing thoughts of suicide
  • People who regularly need to work night shifts or frequently care for children or elderly people during the night

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Tiantan Hospital
Registry
ClinicalTrials.gov
Start date
12 June 2025
Est. completion
31 March 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The total consumption of rimazolen

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov